BACKGROUND: A population-based cervical cancer screening programme is implemented in the Czech Republic. However, participation is insufficient among women over 50 years. This study aimed to estimate the potential improvement in participation through directly mailed HPV self-sampling kits (HPVssk) compared with standard invitation letters in women aged 50-65 non-participating in screening. METHODS: The study recruited 1564 eligible women (no cervical cancer screening in the last 3 years or more, no previous treatment associated with cervical lesions or cervical cancer). Eight hundred women were mailed with an HPVssk (HPVssk group), and 764 women were sent a standard invitation letter (control group) inviting them to a routine screening (Pap test). The primary outcome was a comparison of the overall participation rate between study groups using a binominal regression model. RESULTS: The participation rate in the HPVssk group was 13.4% [95% confidence interval (CI) 11.2-15.9%; 7.4% of women returned the HPVssk and 6.0% attended gynaecological examination] and 5.0% (95% CI 3.6-6.8%) in the control group. Using the binominal regression model, the difference between the groups was estimated as 7.6% (95% CI 5.0-10.2%; P < 0.001). In the HPVssk group, 22% of women who returned HPVssk had a positive result and 70% of them underwent a follow-up examination. CONCLUSIONS: Compared with traditional invitation letters, the direct mailing of the HPVssk achieved a significantly higher participation rate, along with a notable HPV positivity rate among HPVssk responders. This approach offers a potentially viable method for engaging women who have not yet attended a cervical screening programme.

Centre of Outpatient Gynaecology and Primary Care Brno Czech Republic

Department of Obstetrics Gynaecology and Neonatology General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

Laboratory of Experimental Medicine University Hospital Olomouc Olomouc Czech Republic

RBP Health Insurance Company Ostrava Czech Republic

Unilabs Pathology K S Prague Czech Republic

Zobrazit více v PubMed

Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. PubMed

Arbyn M, Weiderpass E, Bruni L, et al.Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8:e191–203. PubMed PMC

Lim AWW. Will COVID-19 be the tipping point for primary HPV self-sampling? Cancer Epidemiol Biomarkers Prev 2021;30:245–7. PubMed

Arbyn M, Smith SB, Temin S, et al.; Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 2018;363:k4823. PubMed PMC

WHO. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: WHO, 2020.

IARC. Cervical Cancer Screening. IARC Handbooks of Cancer Prevention, Vol. 18. 2022. Available at: https://publications.iarc.fr/604 (18 August 2023, date last accessed).

Arbyn M, Castle PE, Schiffman M, et al.Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening. Int J Cancer 2022;151:308–12. PubMed

Chao YS, McCormack S.. HPV Self-Sampling for Primary Cervical Cancer Screening: A Review of Diagnostic Test Accuracy and Clinical Evidence—An Update. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health, 2019. (CADTH Rapid Response Reports). PubMed

Arbyn M, Verdoodt F, Snijders PJF, et al.Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172–83. PubMed

Nelson EJ, Maynard BR, Loux T, et al.The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect 2017;93:56–61. PubMed

Wong ELY, Cheung AWL, Wong AYK, Chan PKS.. Acceptability and feasibility of HPV self-sampling as an alternative primary cervical cancer screening in under-screened population groups: a cross-sectional study. Int J Environ Res Public Health 2020;7:6245. PubMed PMC

Inturrisi F, Aitken CA, Melchers WJG, et al.Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: an observational study. Lancet Reg Health Eur 2021;11:100235. PubMed PMC

Costa S, Verberckmoes B, Castle PE, Arbyn M.. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br J Cancer 2023;128:805–13. PubMed PMC

Gupta S, Palmer C, Bik EM, et al.Self-sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health 2018;6:77. PubMed PMC

Yeh PT, Kennedy CE, Vuyst H D, Narasimhan M.. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health 2019;4:e001351. PubMed PMC

Malone C, Barnabas RV, Buist DSM, et al.Cost-effectiveness studies of HPV self-sampling: a systematic review. Prev Med 2020;132:105953. PubMed PMC

Mezei AK, Armstrong HL, Pedersen HN, et al.Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. Int J Cancer 2017;141:437–46. PubMed

Májek O, Dušková J, Dvořák V, et al.Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic. Eur J Cancer Prev 2017;26:232–9. PubMed

Tachezy R, Hamšíková E, Šmahelová J.. Cervical cancer screening in the Czech Republic. Cent Eur J Public Health 2008;16(Suppl):S31–2.

GynUltrazvuk.cz. Doporučené postupy ČGPS ČLS JEP. Available at: https://www.gynultrazvuk.cz/doporucene-postupy (15 September 2023, date last accessed).

Majek O, Ngo O, Danes J, et al.Integration of personalised invitation system to cancer screening programmes in the Czech Republic. Eur J Public Health 2016;26(Suppl 1):ckw171.025.

Chloupkova R, Benacek P, Ngo O, et al.Narodni Screeningove Centrum: Datovy Portal Screeningovych Programu. Available at: https://nsc.uzis.cz/data (25 July 2023, date last accessed).

Altová A, Kulhánová I, Brůha L, Lustigová M.. Breast and cervical cancer screening attendance among Czech women. Cent Eur J Public Health 2021;29:90–5. PubMed

Pehalova L, Krejci D, Snajdrova L, Dusek L.. Cancer incidence trends in the Czech Republic. Cancer Epidemiol 2021;74:101975. PubMed

Dušek L, Mužík J, Kubásek M, et al.Epidemiology of Malignant Tumours in the Czech Republic. 2005. Available at: http://www.svod.cz (30 November 2023, date last accessed).

Ondryášová H, Koudeláková V, Drábek J, et al.Utilization of self-sampling kits for HPV testing in cervical cancer screening—pilot study. Ceska Gynekol 2015;80:436–43. PubMed

Jaworek H, Koudelakova V, Drabek J, et al.A head-to-head analytical comparison of Cobas 4800 HPV, PapilloCheck HPV screening, and LMNX Genotyping Kit HPV GP for detection of human papillomavirus DNA in cervical and cervicovaginal swabs. J Mol Diagn 2018;20:849–58. PubMed

Jaworek H, Koudelakova V, Oborna I, et al.Prevalence and genotype distribution of human papillomavirus in Czech non-vaccinated heterosexual couples. Virol J 2021;18:80. PubMed PMC

National Screening Centre. Documents—Optimisation of the Cervical Cancer Screening Programme by Introducing HPV DNA Detection by Self-Testing Kits in Women Who Do Not Attend the Current Screening Programme in the Long Term. Available at: https://nsc.uzis.cz/zdravycipek/index.php?pg=dokumenty (22 June 2023, date last accessed).

van Baars R, Bosgraaf RP, ter Harmsel BWA, et al.Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol 2012;50:3937–43. PubMed PMC

Sultana F, English DR, Simpson JA, et al.Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia. Int J Cancer 2016;139:281–90. PubMed

Verdoodt F, Jentschke M, Hillemanns P, et al.Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015;51:2375–85. PubMed

Racey CS, Withrow DR, Gesink D.. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health 2013;104:e159–66. PubMed PMC

National Screening Centre. Outputs of the Project Data Warehouse for Implementation of Screening Programmes. Available at: https://nsc.uzis.cz/res/file/vystupy/datova-zakladna/evaluacni-zprava-screeningu-cervikalniho-karcinomu.pdf (3 September 2023, date last accessed).

Wright TC, Stoler MH, Behrens CM, et al.The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 2012;206:46.e1–46.e11. PubMed

Serrano B, Brotons M, Bosch FX, Bruni L.. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 2018;47:14–26. PubMed

Duffy SW, Myles JP, Maroni R, Mohammad A.. Rapid review of evaluation of interventions to improve participation in cancer screening services. J Med Screen 2017;24:127–45. PubMed PMC

MacDonald EJ, Geller S, Sibanda N, et al.Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: a community-based cluster randomised controlled trial. Aust N Z J Obstet Gynaecol 2021;61:135–41. PubMed

Smith MA, Hall MT, Saville M, et al.Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiol Biomarkers Prev 2021;30:268–77. PubMed